Analysts expect Intellia Therapeutics, Inc. to report revenue of 10.30 M for Q3 26, against a range of 9.45 M to 11.15 M. The most recent reported quarter, Q2 26, came in at 7.66 M, a 43.4% miss against the 13.54 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 9.11 M | 12.87 M | 16.63 M | 14.24 M | 13.78 M | 23.02 M | 15.05 M | 7.66 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 9.00 M | 9.45 M | 14.52 M | 13.09 M | 15.80 M | 12.69 M | 14.92 M | 14.61 M | 11.15 M | 19.05 M | 11.60 M | 16.37 M | 18.56 M | 37.02 M | 51.25 M | 68.15 M | ||||||||||
| Low Estimate | 8.44 M | 8.06 M | 12.09 M | 11.56 M | 13.47 M | 11.80 M | 13.92 M | 12.48 M | 9.45 M | 16.45 M | 9.92 M | 15.25 M | 16.69 M | 30.60 M | 45.50 M | 61.58 M | ||||||||||
| Consensus Estimate | 8.72 M | 8.75 M | 13.30 M | 12.32 M | 14.64 M | 12.24 M | 14.42 M | 13.54 M | 10.30 M | 17.75 M | 10.76 M | 15.81 M | 17.63 M | 33.81 M | 48.38 M | 64.87 M |
Analysts expect Intellia Therapeutics, Inc. to report earnings per share of -0.77 for Q3 26, against a range of -0.83 to -0.71. The most recent reported quarter, Q2 26, came in at -0.80, a 5.9% beat against the -0.85 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.34 | -1.27 | -1.10 | -0.98 | -0.92 | -0.83 | -0.81 | -0.80 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.34 | -1.18 | -1.23 | -0.97 | -0.94 | -0.90 | -0.87 | -0.82 | -0.71 | -0.69 | -0.81 | -0.75 | -0.66 | -0.52 | -0.46 | -0.48 | ||||||||||
| Low Estimate | -1.54 | -1.30 | -1.41 | -1.15 | -1.12 | -1.08 | -1.03 | -0.88 | -0.83 | -0.83 | -0.97 | -0.87 | -0.72 | -0.62 | -0.52 | -0.54 | ||||||||||
| Consensus Estimate | -1.44 | -1.24 | -1.32 | -1.06 | -1.03 | -0.99 | -0.95 | -0.85 | -0.77 | -0.76 | -0.89 | -0.81 | -0.69 | -0.57 | -0.49 | -0.51 |
Pull Wall Street consensus for Intellia Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NTLA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NTLA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NTLA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();